TRML
Tourmaline Bio Inc.
$47.75
+$0.02(+0.04%)
75
Overall
--
Value
75
Tech
--
Quality
Market Cap
$1.23B
Volume
851.23K
52W Range
$11.56 - $47.77
Target Price
$48.55
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $47.5M | $19.7M | $45.4M | $89.7M | ||
| Research & Development | $34.2M | $17.5M | $32.4M | $67.0M | ||
| Research Expense | $34.2M | $17.5M | $32.4M | $67.0M | ||
| Selling, General & Administrative | $13.3M | $2.2M | $13.0M | $22.7M | ||
| Selling & Marketing Expenses | $100.0K | -- | -- | -- | ||
| General & Administrative Expenses | $13.3M | $2.2M | $13.0M | $22.7M | ||
| Salaries & Wages | -- | -- | $5.8M | $6.6M | ||
| Depreciation & Amortization | $600.0K | $1.4M | $33.0K | $39.0K | ||
| Depreciation & Amortization | $600.0K | $1.4M | $33.0K | $39.0K | ||
| Other Operating Expenses | $700.0K | $1.0M | -- | -- | ||
| OPERATING INCOME | ||||||
| Operating income | $-47.5M | $-19.7M | $-45.4M | $-89.7M | ||
| EBITDA | $-46.8M | $-19.7M | $-42.0M | $-73.0M | ||
| NON-OPERATING ITEMS | ||||||
| Intinc | $-326.0K | $2.6M | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-326.0K | $2.6M | $200.0K | $5.7M | ||
| Other Income/Expense | $65.0K | $643.0K | $-3.3M | $-16.5M | ||
| Other Special Charges | $4.0M | -- | $3.3M | $16.5M | ||
| SPECIAL ITEMS | ||||||
| Other Impairment Of Capital Assets | -- | $200.0K | -- | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-47.9M | $-19.7M | $-42.1M | $-73.2M | ||
| Pre-Tax Income | $-47.9M | $-19.7M | $-42.1M | $-73.2M | ||
| NET INCOME | ||||||
| Net Income | $-47.8M | $-19.7M | $-42.1M | $-73.2M | ||
| Net Income (Continuing Operations) | $-47.8M | $-19.7M | $-42.1M | $-73.2M | ||
| Net Income (Discontinued Operations) | $-47.8M | $-19.7M | $-42.1M | $-73.2M | ||
| Net Income (Common Stockholders) | $-47.9M | $-19.7M | $-42.1M | $-73.2M | ||
| Normalized Income | $-37.1M | -- | -- | $-72.5M | ||
| TOTALS | ||||||
| Total Expenses | $47.5M | $19.7M | $45.4M | $89.7M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $2.9M | $4.1M | $4.7M | $25.3M | ||
| Average Shares Outstanding (Diluted) | -- | $4.1M | $4.7M | $25.3M | ||
| Shares Outstanding | $4.1M | $4.2M | $25.6M | $25.7M | ||
| Basic EPS | $-16.4 | $-17.9 | $-8.87 | $-2.89 | ||
| Basic EPS (Continuing Operations) | $-16.4 | $-17.9 | $-8.87 | $-2.89 | ||
| Diluted EPS | $-16.4 | $-17.9 | $-8.87 | $-2.89 | ||
| Diluted EPS (Continuing Operations) | -- | $-17.9 | $-8.87 | $-2.89 | ||
| OTHER METRICS | ||||||
| Other Gand A | $13.3M | $2.2M | $13.0M | $22.7M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRML | $47.75 | +0.0% | 851.23K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |